Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

US Department of Justice
Teva
Fish and Richardson
Cipla
Cantor Fitzgerald
Citi
Chubb
McKesson
Chinese Patent Office

Generated: December 19, 2018

DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR ZONISAMIDE

« Back to Dashboard

Clinical Trials for Zonisamide

Trial ID Title Status Sponsor Phase Summary
NCT00047567 Open-label Adjunctive Zonisamide for Bipolar Disorder Terminated Elan Pharmaceuticals Phase 4 To study the safety and efficacy of zonisamide as adjunctive therapy for children and adolescents with bipolar I or II disorder.
NCT00055484 A Study to Measure the Safety and Effectiveness of Zonisamide in Subjects With Migraine Headache Completed Elan Pharmaceuticals Phase 2 The purpose of this study is to determine if zonisamide is effective as a preventative medication for individuals with migraine headache.
NCT00056576 Dose Response Study of Zonegran in Patients With Newly Diagnosed Epilepsy Completed Eisai Inc. Phase 3 The purpose of this study is to determine whether zonisamide alone is effective as a treatment for epilepsy in newly diagnosed cases.
Trial ID Title Status Sponsor Phase Summary

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Clinical Trial Conditions for Zonisamide

Condition Name

Condition Name for Zonisamide
Intervention Trials
Epilepsy 17
Healthy 6
Obesity 6
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Condition MeSH

Condition MeSH for Zonisamide
Intervention Trials
Seizures 14
Epilepsy 12
Alcoholism 6
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Locations for Zonisamide

Trials by Country

Trials by Country for Zonisamide
Location Trials
United States 98
India 12
Australia 11
Germany 10
Hungary 7
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Trials by US State

Trials by US State for Zonisamide
Location Trials
Massachusetts 6
California 6
Connecticut 6
Florida 6
Maryland 5
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Progress for Zonisamide

Clinical Trial Phase

Clinical Trial Phase for Zonisamide
Clinical Trial Phase Trials
Phase 4 17
Phase 3 15
Phase 2/Phase 3 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Status

Clinical Trial Status for Zonisamide
Clinical Trial Phase Trials
Completed 38
Terminated 11
Recruiting 5
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Sponsors for Zonisamide

Sponsor Name

Sponsor Name for Zonisamide
Sponsor Trials
Eisai Inc. 15
Eisai Limited 6
Eisai Korea Inc. 4
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Sponsor Type

Sponsor Type for Zonisamide
Sponsor Trials
Industry 41
Other 39
NIH 7
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Julphar
Baxter
Mallinckrodt
Colorcon
Express Scripts
Federal Trade Commission
Argus Health
Daiichi Sankyo
Deloitte

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.